An Experienced Partner
for Bringing Advanced
Cell and Gene Therapies
to Market

Cell and gene therapies, oncolytic viruses and vaccines, and radiolabeled ligands are highly promising treatment modalities, but their newness adds a great deal of complexity to the development and manufacturing path. From devising appropriate immunogenicity assays to maintaining strict chain-of-identity tracking for autologous treatments, these approaches require a clinical development partner with flexible processes and specialized expertise in both gene therapy and cell therapy development.

At Precision, we understand the logistical and scientific nuances involved in developing these exciting new approaches and we have the track record to prove it.

Cell Therapy

Our experience developing multiple types of cellular therapies gives us the understanding to develop bespoke solutions for each therapeutic cell type including CAR T cells, stem cells, & tumor-infiltrating lymphocytes.

Gene Therapy

With leadership in immunogenicity, a regulatory team that coordinates therapeutic and companion diagnostic strategy, and a focus on executing end-to-end clinical trials, Precision is well-positioned to guide successful gene therapy development.

Cell and Gene Therapy Manufacturing

Through our partnerships with the pioneers of cell and gene therapy, we have developed best practices that speed product to market—and built the largest advanced therapy manufacturing footprint in the world.

Advancing preclinical through pivotal cell and gene therapy studies with logistical and scientific expertise

With 45+ preclinical through phase III studies successfully completed and a dedicated team with even broader first-hand experience, Precision is uniquely equipped to advance development of cell and gene therapies, oncolytic viruses and vaccines, and radiolabeled ligands.

Cell therapy study experience
  • CAR T cells
  • Stem cells
  • Autologous and allogeneic products
  • Tumor-infiltrating lymphocytes
  • TCRs Therapy


Gene therapy examples and study experience


  • Leber’s congenital amaurosis
  • AADC deficiency
  • Recurrent glioblastoma or gliosarcoma
  • Hemophilia B

Gene Therapy Vectors:

  • Multiple AAV serotypes
  • Lentivirus

See all >

Oncolytic virus and vaccine study experience
  • Oncolytic virus
  • Oncolytic adenovirus
  • Cancer Vaccine
  • AAV


Radiolabeled study experience
  • Advanced Solid Tumor (ST), Head and Neck, NSCLC
  • Prostate/Solid tumour
  • Metastatic Cancer Expressing NTSR-1

Case Study: Navigating logistical complexity in matched cellular therapy trials

Sponsors of cellular therapy trials face enormous complexities coordinating site and manufacturing schedules and standards. The challenges are multifold and include: disparity among sites, multiple samples with unique collection requirements and pressure to coordinate collection timing. See the processes Precision implemented to help sponsors, manufacturing facilities and sites mitigate potential issues.

Partner with the leader in development, manufacturing and commercialization for cell and gene therapies

Delivering a cell or gene therapy to market requires a nuanced, comprehensive and integrated approach. That’s why all Precision clients have access to ADVANCE. The Precision ADVANCE cell and gene therapy collective brings together our unique expertise and capabilities across the continuum of early development, biological manufacturing and commercialization. These interconnected services support and protect the uninterrupted advance of your therapy.

Discover how our cell and gene therapy expertise can advance your clinical development program

Discover how our cell and gene therapy expertise can advance your clinical development program

Services that support the development of cell & gene therapies

Clinical Development Strategy

Tailored strategies consider the scientific, regulatory, and commercial factors that shape each trial, mitigating risk and advancing the development pathway.

Immune Monitoring

Leverage sophisticated immune monitoring approaches, including flow, Epiontis ID immune cell phenotyping, and cytokine profiling, to characterize the immune cells in your samples and understand their impact on patient biology.

Bioanalytical Testing

Bioanalytical analysis of biologics, cell therapies, gene therapies, and companion diagnostics development from the globally-recognized leaders in immunogenicity testing.

Explore other areas of expertise